Trademarkia Logo

Canada

C$
Trademark Search in Canada
4D

View On IC.GC.CA

4D
REGISTERED

on 27 Sept 2019

Last Applicant/ Owned by

4D PHARMA PLC

9 Bond Court,Leeds, England, LS1 2JZ

GB

Serial Number

1819772 filed on 25th Jan 2017

Registration Number

TMA1056548 registered on 27th Sept 2019

Registration expiry Date

27th Sept 2029

Correspondent Address

FASKEN MARTINEAU DUMOULIN LLP

333 BAY STREET, SUITE 2400BAY ADELAIDE CENTRE, BOX 20TORONTO

ONTARIO

CA

M5H2T6

4D

Trademark usage description

chemicals for use as pharmaceuticals; chemicals used in the manufacture of pharmaceuticals; raw proteins for use as pharmaceuticals; raw proteins used Read More

Classification Information

Class [001]
Chemicals for use as pharmaceuticals; chemicals used in the manufacture of pharmaceuticals; raw proteins for use as pharmaceuticals; raw proteins used in the manufacture of pharmaceuticals

Classification kind code

11

Class [005]
Pharmaceuticals and pharmaceuticals as live biotherapeutics for the treatment of brain injuries (namely strokes and ischemic events), central nervous system disorders (namely, multiple sclerosis, autism, obsessive compulsive disorder, depression, anxiety and neurodegenerative disorders, namely Parkinson's disease and Alzheimer's Disease), cancer, bowel disorders (namely, visceral hypersensitivity, diarrhea, constipation, bacterial infections, dysbiosis, irritable bowel syndrome and inflammatory bowel disorders, namely Crohn's disease and ulcerative colitis), lung disorders and diseases (namely, asthma, chronic obstructive pulmonary disease and acute respiratory distress syndrome), inflammatory diseases (namely arthritis) and autoimmune diseases; Live biotherapeutics and live biotherapeutic bacterial formulations for the treatment of brain injuries (namely strokes and ischemic events), central nervous system disorders (namely, multiple sclerosis, autism, obsessive compulsive disorder, depression, anxiety and neurodegenerative disorders, namely Parkinson's disease and Alzheimer's Disease), cancer, bowel disorders (namely, visceral hypersensitivity, diarrhea, constipation, bacterial infections, dysbiosis, irritable bowel syndrome and inflammatory bowel disorders, namely Crohn's disease and ulcerative colitis), lung disorders and diseases (namely, asthma, chronic obstructive pulmonary disease and acute respiratory distress syndrome), inflammatory diseases (namely arthritis) and autoimmune diseases; Preparations of microorganisms for the treatment of brain injuries (namely strokes and ischemic events), central nervous system disorders (namely, multiple sclerosis, autism, obsessive compulsive disorder, depression, anxiety and neurodegenerative disorders, namely Parkinson's disease and Alzheimer's Disease), cancer, bowel disorders (namely, visceral hypersensitivity, diarrhea, constipation, bacterial infections, dysbiosis, irritable bowel syndrome and inflammatory bowel disorders, namely Crohn's disease and ulcerative colitis), lung disorders and diseases (namely, asthma, chronic obstructive pulmonary disease and acute respiratory distress syndrome), inflammatory diseases (namely arthritis) and autoimmune diseases

Classification kind code

11

Class [042]
Scientific research and development services in the field of pharmaceuticals, pharmaceuticals as live biotherapeutics, live biotherapeutics, live biotherapeutic bacterial formulations and preparations of microorganisms for the treatment of brain injuries (namely strokes and ischemic events), central nervous system disorders (namely, multiple sclerosis, autism, obsessive compulsive disorder, depression, anxiety and neurodegenerative disorders, namely Parkinson's disease and Alzheimer's Disease), cancer, bowel disorders (namely, visceral hypersensitivity, diarrhea, constipation, bacterial infections, dysbiosis, irritable bowel syndrome and inflammatory bowel disorders, namely Crohn's disease and ulcerative colitis), lung disorders and diseases (namely, asthma, chronic obstructive pulmonary disease and acute respiratory distress syndrome), inflammatory diseases (namely arthritis) and autoimmune diseases; microbiology research and development into live biotherapeutics

Classification kind code

11

Mark Details

Serial Number

1819772

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 190
on 21st Aug 2019		Registration Pending
Submitted for opposition 42
on 29th May 2019		Advertised
Submitted for opposition 26
on 9th May 2019		Approved
Submitted for opposition 27
on 21st Mar 2019		Approval Notice Sent
Submitted for opposition 12
on 8th May 2018		Extension of Time
Submitted for opposition 22
on 6th Nov 2017		Search Recorded
Submitted for opposition 20
on 6th Nov 2017		Examiner's First Report
Submitted for opposition 31
on 30th Jan 2017		Formalized
Submitted for opposition 1
on 26th Jan 2017		Created
Submitted for opposition 30
on 25th Jan 2017		Filed